City University of New York (CUNY)

CUNY Academic Works
Dissertations, Theses, and Capstone Projects

CUNY Graduate Center

5-2019

Implications of Vestibular Dysfunction Among the Aging
Population: A Pocket Guide for Health Care Professionals
Maia L. Weisenfeld
The Graduate Center, City University of New York

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/gc_etds/3145
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

IMPLICTIONS OF VESTIBULAR DYSFUNCTION
AMONG THE AGING POPULATION
A Pocket Guide for Health Care Professionals

by

MAIA WEISENFELD

A capstone research project submitted to the Graduate Faculty in Audiology in partial fulfillment of the
requirements for the degree of Doctor of Audiology, The City University of New York
2019

© 2019
MAIA WEISENFELD
All Rights Reserved
ii

IMPLICTIONS OF VESTIBULAR DYSFUNCTION
AMONG THE AGING POPULATION
A Pocket Guide for Health Care Professionals

by

MAIA WEISENFELD

This manuscript has been read and accepted for the Graduate Faculty in Audiology in
satisfaction of the capstone project requirement for the degree of Au.D.

___________________
Date

___________________________________________
___________________________________________
Chair of Examining Committee

___________________
Date

___________________________________________
___________________________________________
Acting Executive Officer

The City University of New York

iii

Abstract
IMPLICTIONS OF VESTIBULAR DYSFUNCTION
AMONG THE AGING POPULATION
A Pocket Guide for Health Care Professionals

by

Maia Weisenfeld

Advisor: Dr. Barbara Weinstein, Ph.D.

The goal of this health information booklet is to provide healthcare professionals with the appropriate
tools and information required to ensure all patients with a vestibular impairment are cared for and treated
appropriately. The following guide includes overview of the vestibular system, vestibulotoxic
medications, and common vestibular disorders. These notable areas are required for appropriate treatment
and referral to other professionals for treatment.
Keywords: vestibular dysfunction, central pathology, peripheral pathology, vestibulotoxicity, balance
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Introduction

By the year 2030, it is estimated that 20% of the United States population will be persons
aged 65 and over. From 2000 to 2010 alone this age group grew 15% from 35 million to 40.3
million. This increasing population will have a substantial effect on the health care system,
particularly emergency medicine. From 2009 to 2010, a total of 19.6 million emergency
department visits in the United States were made by persons aged 65 and over. Of those visits,
29% were related to injury and an even higher percentage for those aged 85 and over (Albert,
McCaig & Ashman, 2013). In the United States, unintentional falls are the most common cause
of nonfatal injuries for people older than 65 years (Currie, 2008). Falls have a positive
correlation with age. As a result, the number of emergency department visits for falls increases
with age.
Vestibular dysfunction and a degenerating vestibular system can lead to falls. Postural
control is mediated by input arising from the visual proprioceptive and vestibular systems.
Altered function of these systems with increasing age may lead to impaired balance and
increased falls risk in older adults (Liston et al., 2014). As reported by Agrawal et al. (2009),
persons with vestibular dysfunction are more likely to report dizziness or a history of falls. In
their study, 26.8% of participants with known vestibular dysfunction had an 8-fold increase in
the odds of falling. Among those participants aged 80 years and older, the odds of falling were 7fold higher compared to the participants in their 40s.
An important finding in the study performed by Liston et al (2014) was that 80% of older
adults with a history of falls had an unidentified vestibular impairment. Additionally, report of
dizziness and/or vertigo increased with age. Vestibular vertigo was noted to be three times more

frequent among the older participants than the younger participants. Unexplained fall related
injuries in the emergency department have been associated with vestibular complaints as
vestibular disorders significantly decrease balance therefore increasing the likelihood of falls
(Alghadir, Iqbal & Whitney, 2012).
According to Currie (2008), up to 32 percent of community-dwelling individuals over the
age of 65 fall each year. For those 65 years of age and older, fall-related injuries are the most
common cause of accidental death, resulting in approximately 41 fall-related deaths per 100,000
people per year (Currie, 2008). In conjunction with the catastrophic numbers of falls, injuries
related to falls and deaths related to falls, the increased medical attention and reduced autonomy
for persons over 65 years is a societal toll that must be addressed. When appropriately diagnosed
and referred to fall risk-reduction programs, the US Centers for Disease Control reported
effectiveness in reducing the risk of falls in community-dwelling older adults (Zuniga et al.,
2012).
In addition to a degenerating vestibular system, the aging process is also known to impact
the auditory system resulting in hearing loss. Hearing loss has been associated with increased
risk of falls. Those individuals with hearing loss are noted to have 2.39 times greater odds of
falling than those without hearing loss (Jiam, Li & Agrawal, 2013). More specifically, hearing
loss is noted to be significantly correlated with reduced saccular function. As a result, older
individuals with high-frequency hearing loss should be screened for fall risks. This screening
should consist of vestibular evaluations including cervical vestibular evoked myogenic potentials
(Zuniga et al., 2012).
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These findings have important clinical implications for the assessment and rehabilitation
of the aging population. The British and American Geriatrics Society joint guideline for falls
prevention recommends a balance, gait and mobility assessment however vestibular testing is not
explicitly incorporated (Liston et al., 2014). Those presenting to the emergency department or
other healthcare office who have difficulty ambulating, history of falls or symptoms of dizziness
and/or vertigo should always be examined for a peripheral or central vestibular impairment
(Alghadir, Iqbal & Whitney, 2012). As reported by Zamergrad et al., (2017), a staggering 7481% of peripheral vestibular disorders are not appropriately diagnosed. Referring to audiologists
and/or other balance specialists is the first step in addressing these problems.
Once appropriately evaluated, those with vestibular dysfunction can be referred for
treatment/management. Approximately 50-80% of those who receive vestibular rehabilitation
achieve significant symptom, gait and postural stability improvements (Liston et al., 2014).
Improvements in quality of life have also resulted from vestibular rehabilitation (Alghadir, Iqbal
& Whitney, 2012). By increasing awareness and education of healthcare professionals such as
nurses, nurse practitioners, physician assistants, residents and medical doctors in emergency
medical settings as well as general practices, appropriate assessment and treatment can reduce
the catastrophic toll that falls, and vestibular dysfunction have on those aged 65 and over. To
fully understand the impairments, background knowledge on the vestibular system, vestibular
disorders and vestibulotoxic medications is pertinent for medical professionals.
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The Vestibular System

Figure 1. The bony and membranous labyrinths of the inner ear.

The vestibular system is divided into two separate but conjoining systems: the peripheral
vestibular system and the central vestibular system. Together, these systems are responsible for
sensing motion of the head, maintaining postural control, and providing stability of images
during motion. The peripheral vestibular system is more commonly referred to when referencing
dizziness or vertigo. It is located in the petrous portion of the temporal bone, which lies in the
otic capsule. Housed within this region are the bony and membranous labyrinths of the
peripheral vestibular system.
Table 1. Structures of the bony and membranous labyrinths.
•
•
•
•

THE BONY LABYRINTH
Cochlea
Vestibule
Semicircular Canals
Contains perilymph

THE MEMBRANOUS LABYRINTH
• Cochlear Duct
• Otoliths
o Saccule
o Utricle
• Semicircular Canal Ducts
• Contains endolymph
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The vestibular portion of the eighth cranial nerve – the vestibulocochlear nerve,
innervates the peripheral vestibular system. This vestibular nerve has two branches: the superior
vestibular nerve and the inferior vestibular nerve (Khan & Chang, 2013). Proper function of the
superior and inferior
branches is necessary to
maintain function of the
semicircular canals, the
utricle and the saccule.
Figure 2. Superior and Inferior Vestibular Nerve innervation.

A primary function of the peripheral vestibular system is to detect head acceleration. The
semicircular canals are responsible for angular acceleration while the otoliths are responsible for
linear acceleration (Day & Fitzpatrick, 2005). The semicircular canals are oriented roughly 90
degrees from one another with the lateral semicircular canal titled approximately 30 degrees
backwards. Located at the end of each semicircular canal is a bulge known as the ampulla.
Within this bulge is the cupula – a gelatinous structure that houses the crista ampullaris. The
crista ampullaris is a cone like structure that contains hair cells needed to detect rotational head
movement (Khan & Chang, 2013). This type of movement is known as angular acceleration. For
example, when the head turns
right, hair cells in the right lateral
semicircular canal are excited
while hair cells in the left lateral
semicircular canal are inhibited.
This alerts the brain that the head
Figure 3. Cupula deflection during angular acceleration.
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is turning right, not left.

The saccule and utricle are responsible for linear acceleration - that is, how the head
moves with respect to gravity (ex: tilting forwards). Stereocilia and kinocilium of sensory hair
cells are embedded within otolithic membrane, a gel like structure, which lies superior to the
maculae. Located within the otolithic membrane are calcium carbonate crystals called otoconia.
The otoconia provide internal mass to the otolithic organs. This increases the specific gravity
above that of the endolymph resulting in the maculae of the otolithic organs being responsive to
linear acceleration (Khan &
Chang, 2013). When the head
moves up or down, be it a
person sits up or lies down,
the otoconia are displaced
leading to excitation of the
utricle and saccule.

Figure 4. Deflection of kinocilium and stereocilia during linear
acceleration.

Dysfunction at any point in the peripheral vestibular system can lead to imbalance,
dizziness, vision illusions or falls. As healthcare professionals, it is our responsibility to identify
a patient who may suffer from vestibular dysfunction. Unfortunately, the signals are not always
obvious and concomitant problems lead to unidentified vestibular issues or misdiagnoses.
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The Aging Vestibular System
The bony labyrinth undergoes degenerative changes as the body ages. Sensory receptors
(hair cells) decrease in number and peripheral neural fibers are reduced. The saccule and utricle
lose about 25 percent of their hair cells whereas the semicircular canals lose about 40 percent.
Beginning around the age of 40, the number of neurons and the size of the neurons that make up
the vestibular nucleus decrease by 3 percent each decade. This decline in vestibular sensory cells
and neural pathways result in age-related reduction in vestibular afferent signals sent and
received by the central nervous system (Anson & Jeka, 2016).
Functional consequences of fewer sensory cells in the semicircular canals and otolithic
organs are reduced sensitivity to gravitational and linear acceleration associated with head and
body position. Reduced saccular function has been linked to age related changes in gait speed in
healthy older adults. A reduction of these sensitivities in the aging vestibular system may
contribute to slower walking as a self-protective strategy to prevent falls in older adults (Anson
& Jeka, 2016). Approximately one third to one half of the population over 65 experiences an
injurious fall annually; 80 percent of falls in a study by Liston et al. (2014) were found to have
vestibular origin. These falls most commonly occur when walking or sitting/standing due to high
head acceleration.
The vestibular system is linked to visuospatial function. As these systems deteriorate,
elderly individuals have trouble with proprioception and spatial navigation. For accurate spatial
awareness, the vestibular system must be intact to serve as an egocentric reference frame. As
their systems age, older adults lose the accuracy of this reference frame. As a result, they have
greater difficulty integrating multisensory cues for navigation. This leads to increased difficulty
walking or standing on uneven or soft surfaces, especially in poorly lit environments. Body
7

sway increases and may be partially responsible for general postural unsteadiness (especially
falls). Equilibrium and balance become impaired especially when fast movement is required
(Anson & Jeka, 2016). Older adults generally adapt by moving slowly and walking with a wide
stance with their feet apart gait to provide greater stability.

How to Assess the Balance and Gait of Your Patients
Both informal and formal evaluations can be used to assess a patient’s balance and gait.
Informally, the following are things to note during a patient’s visit:
Table 2. Informal Observations

Does the patient need assistance rising from their chair?

YES/NO

Does the patient need assistance walking? (Ex: stops to touch the wall or
chair)

YES/NO

Does the patient use a cane or walker?

YES/NO

Is the patient’s gait fluid and continuous?

YES/NO

Does the patient wear appropriate footwear?

YES/NO

Formally, the Tinetti Balance and Gait Test is a useful assessment tool. Listed below is the
grading scale for both balance and gait. A score of 22 or below indicates a patient is at risk.
Table 3. Tinetti Balance and Gait Test. Balance questionnaire.

Balance

Score

Instructions: Patient is seated in a hard armless chair.
Sitting balance
-

Leans or slides in chair = 0
Steady = 1

Arise
-

Unable without help = 0
Able but uses arms to help = 1
Able without use of arms = 2
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Attempts to rise
-

Unable without help = 0
Able, but requires more than one attempt = 1
Able to rise with one attempt = 2

Immediate standing balance (first 5 seconds)
-

Unsteady (staggers, moves feet), marked trunk sway = 0
Steady but uses walker or cane or grabs other object for support = 1
Steady without support = 2

Standing balance
-

Unsteady = 0
Steady, but wide stance or uses cane or other support = 1
Narrow stance without support = 2

Nudge (Patient stands with feet close together, examiner pushes lightly on subject’s sternum with palm
of hand 3 times)
-

Begins to fall = 0
Staggers but catches self = 1
Steady = 2

Eyes closed (Same position as number 6)
-

Unsteady = 0
Steady = 1

Turn 360 degrees
-

Discontinuous steps = 0
Continuous steps = 1
Steady = 2

Sit down
-

Unsafe, misjudged distance, falls into chair = 0
Uses arms or not a smooth motion = 1
Safe, smooth motion = 2

Total

Table 4. Tinetti Balance and Gait Test. Gait questionnaire.

Gait

Score

Instructions: Patient stands with examiner, walks down the hall or across the room at
their usual pace and then back at a rapid pace. Distance should be approximately 25
feet.
Initiation of gait (immediately after told “go”)
-

Hesitancy at start = 0
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-

No hesitancy = 1

Step length and height
Right foot swing
-

Does not pass L stance foot with step = 0
Passes L stance foot =1
R foot does not clear floor completely with step = 0
R foot completely clears floor = 1

Left foot swing
-

Does not pass R stance foot with step = 0
Passes R stance foot =1
L foot does not clear floor completely with step = 0
L foot completely clears floor = 1

Step symmetry
-

R and L step length not equal = 0
R and L step appear equal = 1

Step continuity
-

Stopping or discontinuity between steps = 0
Continuous steps = 1

-

Marked deviation = 0
Mild/moderate deviation or uses walking aid = 1
Straight without walking aid = 2

Path

Trunk
-

Marked sway or uses walking aid = 0
No sway but flexion of knees or back, or spreads arms out while walking = 1
No sway, flexion, arm spread, or walking aid = 2

Walk stance
-

Heels apart = 0
Heels almost touching while walking = 1

Total
Total Balance + Total Gait

____/ 28
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Cognitive and Emotional Ailments and the Aging Vestibular System
In addition to physical ailments associated with vestibular dysfunction in the aging
population, cognitive and emotional ailments are present among this population. Decline in
cognition is widely associated with the aging population. Of lesser awareness is the associated
between the aging vestibular system and mental health. Older adults are more likely to have
anxiety, depression and a fear of falling in light of these vestibular changes. For patients who
complain of dizziness, there is a three-time greater prevalence of self-reported anxiety and a
higher incidence of depression than those who do not complain of dizziness (MacDowell et al.,
2017). Vestibular dysfunction has also been noted to mediate the decline in cognition typically
associated with older age (Anson & Jeka, 2016). The vestibular system makes important
contributions to areas of cognitive function including: spatial awareness, memory, attention and
executive function. Older adults with known vestibular lesions will often complain of memory
loss or “brain fog” (Semenov et al., 2016). Smith et al. (2005) reported that 95% of older adults
with confirmed a confirmed perilymph fistula and/or benign paroxysmal positional vertigo
(commonly referred to as BPPV) had long-term “disorientation” due to their lack of visuospatial
awareness. Of the same population, 85% reported memory loss. Auditory processing deficits
have also been related to older individuals with vestibular impairments (Smith et al., 2005).
In a study by Semenov et al. (2016), older adults with vestibular symptoms had increased
difficulty with activities of daily living. As a result, quality of life is reduced due to limited
independence secondary to vestibular impairments. Unfortunately, there seems to be difficulties
in the ability to identify patients that are considered “high risk” for falls. This difficulty may
come from older adults’ tendencies to overstate their own competence in completing daily tasks.
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For example, many older individuals will say they have no difficulty getting out of bed or rising
from a chair. However, when observed clinically, they struggle with these tasks (Cohen, 2011).
To improve quality of life for the

As hearing
sensitivity and
vestibular
function
decrease..

aging population, these areas of concern
must be addressed. Awareness of the
implications that vestibular impairments
Risk of falls and
associated
emotional
consequences
increase

can have on the aging adult is pertinent in
correctly diagnosing, treating and
supporting these patients.

Figure 5. Relationship between hearing loss and vestibular
impairment with risk of falls and fear of falling.

Hearing Loss and the Aging Vestibular System
As previously noted, older adults with vestibular impairments struggle with mental health
and cognition. Hearing loss is a widely known health concern for the aging population that is
also related to decreased quality of life, reduced cognitive ability, poor emotional status and
increased fear of falling. Older adults with hearing loss have 2.39 times greater odds of falling
than their normal hearing counterparts (Jiam, Li & Agrawal, 2016). More than that, the National
Health and Nutrition Examinations survey (2001-2004) reported that for every 10 dB of hearing
loss, risk of falling increasing 1.4 times (Rumalla, Karim & Hullar, 2014). The association
between hearing loss and falls has been linked to reduced spatial awareness due to the loss of
auditory perception, a reduction in cognitive capacity given the cognitive load of hearing loss,
and the presence of comorbid auditory and vestibular pathologies (Jiam, Li & Agrawal, 2016).
Due to the close anatomical proximity, older adults with degenerating vestibular systems
are likely to have degenerating auditory systems. Adults aged 70 years and older with hearing
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loss are more likely to have reduced saccular function (Zuniga et al., 2012). In the study by
Zuniga et al., (2012), white adult males with history of smoking and noise exposure were the
most likely to have high frequency sensorineural hearing loss and saccular dysfunction. Because
of these findings, it is recommended that older adult patients should be screened for fall risks.
This screening should include referral to audiology for hearing evaluations and balance testing
including cervical vestibular evoked myogenic potential (cVEMP) evaluation to determine
saccular involvement.
Following a hearing test, hearing instruments have been reported to be effective in not
only improving auditory awareness and increasing quality of life but in improving patient’s
balance as well. Vestibular, visual and proprioceptive inputs are critical in maintaining balance
(Shayman, Earheart & Hullar, 2017). The auditory stimulation serves as spatial orienting
landmarks to increase balance and reduce risk of falls. In addition to auditory stimulation,
hearing instruments have been considered to have alerting effects on older individuals and have
caused them to be more aware of their surroundings reducing their risk of falling (Stevens,
Barbour, Gronski & Hullar, 2016).

Hearing
instruments

Increased spatial
and auditory
awareness

Figure 6. Effects of hearing instruments on falls
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Reduced risk of
falling

Vestibular Disorders
Dizziness is a common symptom that is reported to affect more than 90 million
Americans. It is also the most common complaint of patients aged 75 and older (Thompson &
Amedee, 2009). The term dizziness is an umbrella term that is frequently used to describe
various sensations. Understanding the type of dizziness described will allow health care
professionals to better understand their patient’s symptoms to determine the appropriate
intervention and treatment. Ross and Robinson (1984) classified dizziness in four ways:
Table 5. Classification of Dizziness.

Disequilibrium

A sense of imbalance. Characterized by difficulties walking. Present
in Parkinson or Alzheimer’s patients.

Presyncope/faintness

A feeling of impending loss of consciousness. Often caused by
circulatory insufficiency. Anemia, thyroid diseases, hypoglycemia
and medical problems that lessen oxygenation of the brain contribute
to faintness.

Lightheadedness

Likely caused by multiple sensory deficits, anxiety with
hyperventilation and chronic systemic disease

Vertigo

A sensation of rotating or spinning in space. The illusion that one is
moving, or their surroundings are moving is characteristic of vertigo
and differentiates the symptom from other forms of dizziness.

Sample Questions to Ask Your Patients
✓ What does your dizziness feel like?
✓ Do you feel the room or environment spins or are you spinning?
✓ Do you feel like you may fall-down?
✓ Do nausea and vomiting occur at the same time?
✓ How often does it occur?
✓ Does it occur with movement?
✓ Did you have a change in medication at the onset?
✓ Do you have a history of migraines or motion sickness?
14

In addition to straight forward questions, open ended questions will allow you to have a
better understanding of your patient’s symptoms. Symptoms of dizziness or imbalance may be
the result of numerous impairments including vision, proprioception, musculoskeletal, or
vestibular dysfunction (Agrawal et al., 2009). An estimated 30-35% of older adults suffer from
vestibular dysfunction (Anson & Jeka, 2016). Vestibular dysfunction can occur in the peripheral
and central vestibular systems. Awareness of the manifestations and differences between the
various disorders is critical in appropriate evaluation and treatment. The following section will
discuss common vestibular disorders of both the peripheral and central vestibular systems.
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Peripheral Vestibular Disorders
Benign Paroxysmal Position Vertigo
Considered the most common peripheral vestibular disorder, Benign Paroxysmal
Positional Vertigo (BPPV) is reported to affect a staggering 64 of 100,000 Americans
(Froehling, Silverstein, Mohr, et al., 1991). Although it can occur at any time, BPPV typically
appears in the fourth to fifth decades of life (Thompson & Amedee, 2009). Women are two times
more likely to experience BPPV than men. While 95% of cases are considered to be degenerative
or idiopathic, of those cases that are symptomatic, 17% result from head injury and 15% result
from vestibular neuritis. BPPV has also been linked to patient with ailments causing them to be
bed ridden or sedative (Brandt et al., 2013).
BPPV occurs when some of the otoconia become displaced and migrate into one or more
of the semicircular canals. During head movement, the otoconia float within the semicircular
canals. This movement displaces the endolymph causing deflection of the cupula. This deflection
is detected by the brain and in return elicits sensation of perceived movement. This perception
results in rapid eye movement - called nystagmus – and vertigo. Patients who are affect by BPPV
frequently complain of intense, sudden spinning sensation that is often elicited by rolling over in
bed, rising from a sitting position, or turning their head quickly (Thompson & Amedee, 2009).
There are two types of BPPV: Canalithiasis and Cupulothiasis. Determining the type of BBPV
an individual is experiencing is important in determining the appropriate treatment.
Canalithiasis also known as “Typical BPPV” is the most common form of this pathology.
When the head is moved with respect to gravity, the otoconia settle at the lowest portion of the
inner ear – the posterior semicircular canal. The involvement of this posterior semicircular canal
is the defining feature of Canalithiasis. The right posterior semicircular canal is more frequently
16

affected than the left (Brandt et al, 2013). Canalithiasis is characterized by geotropic nystagmus
with the problem ear down, transient nystagmus (typically less than 20 seconds), reversal of
nystagmus with movement in the opposite direction, and fatigue of nystagmus and subjective
vertigo upon repetition of the movement.

Canalithiosis
Symptoms under
one minute
(typically less
than 20 seconds)

BPPV
evoked by
movement
geotropic
nystagmus with
problem ear down
severe vertigo

Cupulothisis
Symptoms lasting
one minute or
greater

Figure 7. Symptoms of Benign Paroxysmal Positional Vertigo and subtypes.

Cupulothiasis is the less common form of BPPV, accounting for approximately 5% of all
cases. With Cupulothiasis, otoconia are not free floating but instead attach to the cupula within
the inner ear (Lee & Kim, 2010). When the head is moved, the additional weight on the otoconia
cause symptoms characteristic of BPPV. Geotropic nystagmus with the problem ear down and
severe vertigo is also typical of Cupulothiasis however; symptoms are noted to last longer than
60 seconds.

Figure 8. Displacement of otoconia in Cupulothiasis BBPV and Canalithiosis BPPV.

17

Although BPPV may resolve on its own, it may persist in 30% of patients (Brandt et al.,
2013). Appropriate identification of the structures involved (typically obtained during a through
medical history) is key in recommended the proper treatment/management. According to Li, Li,
Epley & Weinberg (2000), the costs of BPPV are reported to be more than $2,000 per individual.
Most of these expenses are the result of inappropriate diagnostic procedures and ineffective
therapies. Referral to an audiologist for proper diagnostic evaluation such as the Dix Hallpike
Maneuver is recommended. During the Dix
Hallpike Maneuver, the patient is asked to
turn their head 45 degrees to one side and
then the patient lies back quickly with
support from the audiologist. Once back,
their head will hang supported over the

Figure 9. Performance of the Dix Hallpike
Maneuver

edge of the bed/chair. Eye movements are then observed and recorded using appropriate
equipment. The patient is then returned to upright position. If there is an increase in rapid eye
movements (nystagmus), the procedure is repeated on that side. The same process is then
performed on the other side.
Following diagnosis, referral to a specialist for canalith repositioning maneuvers (such as
the Epley maneuver, Semont’s liberatory maneuver or Brandt–Daroff maneuver) is the key
component in management. The most common repositioning technique is the Epley maneuver.
This is a series of head movements performed in sequence to position. If the patient has a history
of neck or back problems, evaluation and management should be recommended with caution.
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Meniere’s Disease
Also known as primary endolymphatic hydrops, Meniere’s disease is a disorder of the
membranous labyrinth of the inner resulting from disruption in the flow of endolymphatic fluid
(National Institute on Deafness and Other Communication Disorders, 2017). Endolymph is
derived from the stria vascularis and flows through the scala media, up the ductus reuniens into
the saccule and eventually into the endolymphatic sac. The endolymphatic sac acts as an
immuno-defense of the ear. It is responsible for reabsorption of the water content in endolymph
as well as removal of metabolic and cellular debris. A disruption at any point in the
endolymphatic pathway can lead to hearing and balance
problems.
While the exact cause of Meniere’s disease is
unknown, possible etiologies include: hyper secretion of
endolymph from the stria vascularis, under absorption of
endolymph caused by failure of the endolymphatic sac, or
blockage of the endolymphatic ducts, utricular duct,
saccular duct and/or ductus reuniens (Coelho & Lalwani,
2008). Other factors that may affect the excess of
endolymph include abnormal immune response, viral
infection, head trauma, migraines, and allergies –

Figure 10. Healthy inner ear vs. pathologic
inner ear affected by Meniere’s disease.

Meniere's disease symptoms occur more frequently in autumn and spring. One in five patients
with confirmed Meniere’s disease have a positive family history suggesting a genetic
predisposition to the disorder. Overall, there is a multifactorial predisposition to Meniere’s
disease (Da Costa et al., 2002).
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The classic triad of symptoms of Meniere’s disease includes vertigo, hearing loss and
tinnitus. However, this classic triad is only seen in 27% of patients. The fourth common
symptom of Meniere’s disease is aural fullness. In many patients, auditory symptoms alone or
vestibular symptoms alone precede the development of the full-blown symptomatic disease for
many months or years. In the natural progression of the disease, tinnitus and fluctuating hearing
loss may present years before a vertigo episode. Purely vestibular attacks without cochlear
symptoms are relatively uncommon but can be the initial manifestation at the beginning of the
disease. However, since vertigo is often the most alarming symptom, its appearance is frequently
regarded as the onset of the disease. The variation in symptoms is attributed to the four subclassifications of Meniere’s disease (Da Costa et al., 2002).
Table 6. Classification of Meniere’s Disease.

CLASSICAL
MENIERE’S
DISEASE

BILATERAL
MENIERE’S
DISEASE

Episodic vertigo

Bilateral fluctuating

Sensorineural hearing
loss

Recurrent episodes of
vertigo

Tinnitus

Often develops
asymptomatically

Aural fullness

VESTIBULAR
MENIERE’S
DISEASE

COCHLEAR
MENIERE’S
DISEASE

Vertigo attacks identical Fluctuating and
to Classic Meniere’s
progressive hearing loss
Hearing remains normal
Tinnitus and aural
fullness may or may not
be present

Tinnitus and aural
fullness are present
Vertigo is absent

Typically unilateral

Hearing loss associated with Meniere’s disease generally presents as progressive,
fluctuating, sensorineural hearing loss in one ear. Most commonly, audiometric configuration
begins in the low frequencies and progresses into the high frequencies where it may eventually
become a flat hearing loss to varying degree. In addition to hearing loss, those affected by
Meniere’s disease frequently report tinnitus in the affected ear. Most commonly, tinnitus is
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described as a low-pitch, roaring sound. Aural fullness or aural pressure is also a frequent
complaint. While this sensation is typically felt in the ear, it may spread to any part of the head
or even the neck. Those with Meniere’s disease may also complain of hyperacusis or diplacusis.
Hyperacusis is an increased sensitivity to sound. Those with hyperacusis may perceive every
day, normal sounds to be unbearably loud. Diplacusis is described as “double hearing,” where
someone may perceive a sound in a different pitch or at a different time in either ear.
Hyperacusis and diplacusis symptoms are often worse after an episode of Meniere’s disease.
Some can have a condition known as Lermoyez syndrome. In these patients, there is a
paradoxical improvement in hearing following an acute attack. In many cases, tinnitus and
hearing loss are common precursors before the first attack of vertigo (Da Costa et al., 2002).
Vestibular symptoms typically manifest as episodic vertigo also called vertigo attacks.
The vertigo sensation can vary between affected individuals. In some cases, severe vertigo can
cause nausea and/or vomiting. In other cases, vertigo can be a feeling of imbalance that lasts a
long time and occurs in between attacks. Positional vertigo (described under Benign Paroxysmal
Positional Vertigo) can exacerbate or occur between attacks. In rare cases, vestibular symptoms
are so explosive that the patient falls to the ground. These are referred to as “falling spells of
Tumarkin” or more commonly, drop attacks. The duration of vestibular attacks will vary
between patients. In 50% of cases, vertigo attacks last less than one hour – commonly 20
minutes. In 25% of cases, attacks can last between one to two hours. In the remaining 25% of
cases, attacks can last from two hours to one day. The number of vestibular attacks is reported to
range from 3 to over 30 attacks per year per individual (Paparella, Costa, Fox & Yoo, 1991).
Referral to an otolaryngologist and audiologist are recommended for diagnosis and
management of symptoms. Baseline and sequential hearing tests are recommended due to the
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progressive nature of hearing loss associated with Meniere’s disease. Hearing instruments may
beneficial depending on the severity of loss and impact on daily life. Electrocochleography may
be performed by an audiologist to identify Meniere’s disease however, test sensitivity is highly
dependent on the test being performed during an acute attack. Additionally, balance testing and
referral to physical therapy for vestibular rehabilitation can provide patients with compensatory
strategies.
Unfortunately, there is no specific cure or treatment for Meniere’s disease. Lifestyle
modifications such as the CATSS method is often recommended. CATSS includes limiting
caffeine, alcohol, tobacco, salt and stress. Diuretics, antihistamines, anticholinergics, anti-nausea
and anti-vert medications may be taken to varying levels of success to help alleviate symptoms
(Da Costa et al., 2002). For those with severe symptoms that are debilitating, surgical options
such as vestibular neurectomy, labyrinthectomy and endolymphatic sac surgery are available. As
with all surgeries, each has their own risk. With vestibular neurectomy and labyrinthectomy, the
patient must be willing to accept associated side effects such as complete loss of function on the
affected side. Despite being less effective in alleviating symptoms than the previously mentioned
surgical options, endolymphatic sac surgery is the preferred initial surgical intervention for
Meniere’s disease (Kim, Wiet & Battista, 2005). However, like the disease itself, treatment will
vary patient to patient. Understanding the patient’s daily life and their needs will aid in this
decision.
Vestibular Neuritis
Following BPPV and Meniere’s disease, vestibular neuritis is the third most common
cause of peripheral vestibular dysfunction. Strupp and Brandt (2009) reported an annual
incidence of 3.5 per 100,000 persons. Vestibular neuritis is the inflammation of the inner ear as a
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result of an infection that enters the vestibular portion of the eighth cranial nerve. The superior
vestibular nerve is most commonly involved due to its location within the internal auditory canal.
As a result, it is more susceptible to compressive edema (Thompson & Amedee, 2009). Patients
may report an upper respiratory infection or other ailment a few days or even weeks prior to the
onset of symptoms.
Patients affected by vestibular neuritis experience sudden vertigo that is often
accompanied by nausea and vomiting. In addition, patients presenting with vestibular neuritis
typically have gait deviation and tendency to fall. If the lesion is unilateral, patients will typically
fall to the affected side (Brandt et al., 2013). Tinnitus and aural fullness may also accompany
vertiginous symptoms. While neuritis has symptoms similar to other vestibular disorders, hearing
loss is not a symptom of vestibular neuritis. Sudden hearing loss is a differentiating factor
between neuritis and labyrinthitis. It is important to ask a patient presenting with symptoms if
hearing loss was present prior to current symptoms.
Diagnosis of vestibular neuritis is one of exclusion. For this reason, an extensive history
is required. Physical examination is limited given the varying symptoms. A complete
audiological evaluation including videonystagmography/electronystagmography (VNG/ENG)
and vestibular evoked myogenic potentials (VEMPs) is highly recommended to determine site of
lesion. After diagnosis, treatment is also limited. Symptoms may gradually improve but complete
spontaneous recovery is unlikely (Brandt et al., 2013). Anti-vertigo and anti-nausea medications
will be helpful for patient comfort, but long-term use may inhibit compensation. Encouraging
patients to ambulate as soon as possible will promote recovery. Ambulation with support (canes,
walkers, etc.) is recommended. Unfortunately, recurrence of vestibular neuritis is not uncommon.
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Labyrinthitis
Similar to vestibular neuritis, labyrinthitis is the inflammation of the inner ear as the
result of an infection. This particular infection affects the membranous labyrinth therefore
resulting in cochlear and vestibular involvement. Bacteria or viruses can result in labyrinthitis.
Due to antibiotics, bacterial labyrinthitis is less common (Bertholon & Karkas, 2016). Common
viral etiologies include adenovirus, respiratory syncytial virus (RSV), influenza, herpes virus,
hepatitis, polio, cytomegalovirus (CMV), Epstein‐Barr virus, measles, rubella, and mumps. In
addition, chronic middle ear infections can result in labyrinthitis (Herendeen, 2007).
Presentation is similar to vestibular neuritis in that it may be unilateral or bilateral and
presents with sudden and intense vertigo that can affect gait and be accompanied by nausea and
vomiting. In addition to vestibular symptoms, patients presenting with labyrinthitis will also
report sudden hearing loss on the affected side (Thompson & Amedee, 2009).
In the case of labyrinthitis, diagnosis is also one of exclusion. Due to the nature of the
disease – be it viral or bacterial – steroids or antibiotics may be given. If treated promptly,
permanent damage may be avoided (Shupert & Kulick, 2013). A baseline audiological
evaluation should be performed as soon as possible to assess hearing loss. Routine evaluations to
determine improvement or need for intervention (i.e. hearing instruments) should be
recommended. In addition to hearing loss, vestibular symptoms should be treated in the same
manner as vestibular neuritis. As with vestibular neuritis, anti-nausea and anti-vertigo
medications may also be prescribed for patient comfort.
Table 7. Differentiating Labyrinthitis and Vestibular Neuritis

LABYRINTHITIS
•

VESTIBULAR NEURITIS
•

Sudden vertigo that may be
accompanied by nausea and vomiting
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Sudden vertigo that may be
accompanied by nausea and vomiting

•
•
•

•
•

Tinnitus
Aural fullness
Sudden hearing loss

Tinnitus
Aural fullness

Acoustic Neuroma/Vestibular Schwannoma
Acoustic neuromas are the most common intracranial benign neoplasms. One in every
100,000 people per year is affected (Thompson & Amedee, 2009). Acoustic neuromas may also
be called Vestibular Schwannomas as they are the result of abnormal production of Schwann
cells of the vestibular nerve. These tumors were previously thought to affect the superior
vestibular nerve, but more recently research has shown that both the superior and inferior
vestibular portions may be affected. Less than 5% of acoustic neuromas arise from the cochlear
branch of the vestibulocochlear nerve (Khrais, Romano, Sanna, 2008).
There are two categories of acoustic neuromas, sporadic acoustic neuromas or acoustic
neuromas associated with Neurofibromatosis Type II. Sporadic acoustic neuromas are more
common, occur unilaterally and symptoms may not present until later in life. Neurofibromatosis
Type II is associated with bilateral acoustic neuromas that present early in life – typically in the
teenage years. According to West, Møller, Hansen and Cayé-Thomasen (2018), recent studies
have shown that the incidence of sporadic acoustic neuromas is on the rise - an estimated 20
cases per million persons per year.
Although slow growing, as acoustic neuromas become larger, they can compress the
facial, auditory and vestibular nerves. Once compression begins, symptoms arise. As the tumor
arises on the vestibular nerve, balance problems may be one of the first symptoms. However, due
to the body’s ability to compensate – these balance symptoms may go unnoticed. While vertigo
may be associated with a new and smaller tumor, this symptom abates with tumor
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growth (Thompson & Amedee, 2009). Instead, as the tumor grows in size,
imbalance or disequilibrium becomes more prevalent.
Hearing loss is typically progressive, unilateral high frequency sensorineural hearing loss
that presents on the affected. Although typically slow growing, some tumors may grow at a rate
that causes the tumor to cut off bloody supply rapidly causing a sudden hearing loss. Patients
who present with sudden hearing loss should be treated with urgency. Imaging such as MRI is
the gold standard in detecting an acoustic neuroma. Referral to neuro-otology and audiology will
allow for baseline evaluations and appropriate treatment.
As with hearing loss, tinnitus is typically unilateral. Once large enough to compress the
facial nerve or trigeminal nerve, patients may experience facial weakness or
numbness. Diagnosis of acoustic neuroma includes a thorough history and audiological
evaluation including hearing and balance assessments. In addition, imaging is recommended to
confirm or rule out the presence of the neoplasm Magnetic Resonance Imaging is considered the
gold standard. Once confirmed, treatment options range from observation, radiation and surgical
removal.
Semicircular Canal Dehiscence
Semicircular canal dehiscence is also
known as superior semicircular canal
dehiscence (SSCD) given the nature of the
disorder. SSDC is the thinning or absence of
bone over the superior semicircular canal.
This hole creates a third window in addition to
the oval and round windows into the inner ear.
Figure 11. Dehiscence of the superior
semicircular canal.
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This third window allows for the transfer of pressure and sound into the vestibular system
(Thompson & Amedee, 2009). This pressure in the vestibular system sets the vestibular
endolymph into motion resulting in vestibular symptoms.
Patients may present with complaint of hearing their own voice or breath, aural fullness,
vertigo and oscillopsia evoked by loud noises. This sensation of vertigo induced by sound is
known as Tulio’s phenomenon. While frequently loud sounds are the cause of vertiginous
episodes, it is not always true. In addition to Tulio’s phenomenon, Hennebert’s sign is another
phenomenon associated with semicircular canal dehiscence in which pressure applied to the
middle ear results in vertigo and nystagmus (Naert et al., 2017).
In addition to vestibular symptoms, the third window also allows energy from airconducted sounds does not enter directly to the cochlea but instead is partially directed through
the new hole in the semicircular canal which creates an apparent conductive hearing loss. The
severity of the hearing loss is based on the location and size of the dehiscence (Zipser &
Sepahdari, 2014). Hyperacusis, sensitivity to sounds, is also common.
As with all disorders, those with semicircular canal dehiscence may present with varying
symptoms to varying degrees. The study by Naert et al. (2017) revealed that the five most
frequently reported symptoms were spontaneous dizziness, Tulio’s phenomenon, hearing loss,
autophony and Hennebert’s sign. Prior to diagnosis, it is recommended that an audiologist
evaluate patients with suspected semicircular canal dehiscence. In addition to a hearing test,
ocular vestibular evoked myogenic potentials are recommended. These evaluations combined
with computerized tomography to detect the location of the dehiscence will allow for appropriate
diagnosis.
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Table 8. Overview of peripheral vestibular disorders

DISORDER

MOST COMMON
SYMPTOMS

REFERRALS

TREATMENT

BPPV

Dizziness evoked by
movement (i.e. rising
from chair or rolling
over in bed)

ENT, Audiology,
Physical Therapy
if needed

Canalith repositioning
maneuver, vestibular
rehabilitation therapy
if needed

Meniere’s Disease

Aural fullness
Tinnitus
Hearing loss (typically
begins as low
frequency
sensorineural hearing
loss)
Episodic vertigo

ENT, Audiology,
Physical Therapy

Lifestyle
modifications
(CATSS), diuretics,
anti-vert, anti-nausea,
antihistamines,
anticholinergics,
vestibular neurectomy,
labyrinthectomy,
endolymphatic sac
surgery, hearing
instrument(s)

Vestibular Neuritis

Sudden onset
dizziness
Tinnitus
Aural fullness
Sudden onset
dizziness
Tinnitus
Aural fullness
Hearing loss
Dizziness
Unilateral tinnitus
Unilateral aural
fullness
Unilateral hearing loss

ENT, Audiology,
Physical Therapy

Anti-vertigo, antinausea, vestibular
rehabilitation therapy

ENT, Audiology,
Physical Therapy

Anti-vertigo, antinausea, vestibular
rehabilitation therapy,
hearing instrument(s)

ENT, Audiology,
Physical Therapy
if symptoms
worsen

Dizziness
Tulio’s Phenomenon
Oscillopsia
Autophony

ENT, Audiology

Observation, radiation,
surgical removal,
hearing instrument(s),
vestibular
rehabilitation if
needed
Limited treatment or
management of
symptoms, surgical
option for severe cases

Labyrinthitis

Acoustic
Neuroma/Vestibular
Schwannoma

Semicircular Canal
Dehiscence
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Central Vestibular Disorders
Patients presenting with central vestibular disorders more typically present with
imbalance or disequilibrium rather than “true vertigo.” That is, they may not experience a room
spinning sensation. Patients with a central lesion are more likely to have difficulty ambulating –
even with assistance – and their gait is notably impaired. Those with these disorders are likely to
have a wide array of symptoms. A complete neurological evaluation should be done for
appropriate diagnosis and treatment in addition to specialized evaluations.
Vestibular Migraine
Migraines are commonly associated with severe headache, nausea, light sensitivity and
sound sensitivity. Migraines are categorized as migraines with or without aura. Auras refer to
neurological symptoms such as visual disturbances, changes in somatosensory, weakness,
changes in smell and hearing, and dizziness. These typical migraines are reported to affect 10%
of Americans, women more so than men (Thompson & Amedee, 2009). The onset of vestibular
symptoms is reported to occur 8 to 19 years after migraines with or without auras begin. In
postmenopausal women, vestibular migraines with imbalance, dizziness or true vertigo
frequently occur without headaches (Luzeiro, Luis, Goncalves & Martins, 2017).
Within the past few years, vestibular migraines have been recognized as an independent
neurotologic disorder. Of patients that experience migraines, 30 to 50 percent are reported to
experience vertigo (Luzeiro, Luis, Goncalves & Martins, 2017). The large range in percentage of
those experiencing vertigo is the result of the variation between patients experiencing migraines.
Uncertainty in localization and pathophysiology of migraines results in a wide array of clinical
presentations.
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Regardless of diagnostic evaluations available, no single approach is fit for all patients or
for one patient over time. Patients with vestibular migraine may experience different symptoms
with each episode (Furman & Balaban, 2015). Most commonly, vestibular symptoms present as
an aura and can last seconds to hours. The characteristics of dizziness are endless. Some patients
may report imbalance. Some patients may report room-spinning vertigo. Duration and severity of
attacks are also patient-dependent (Furman & Balaban, 2015).
Due to the above noted variations and similar symptomology as other vestibular
disorders, vestibular migraine diagnosis is one of exclusion. To better diagnose and treat
vestibular migraines, the International Headache Society and the Barany Society published
criteria for identifying the disorder in 2013 (Luzeiro, Luis, Goncalves & Martins, 2017). The
ICHD-3 Beta Diagnostic Criteria of Vestibular Migraine is listed below. As with all central
vestibular disorders, a complete neurological evaluation is recommended in addition to vestibular
evaluations. A comprehensive case history will be necessary for appropriate treatment.
Treatment and management options often include lifestyle changes to avoid triggers. Stress
relief, exercise and sleep may aid in this. Anti-nausea, anti-vertigo and no-steroidal antiinflammatory drugs (NSAIDS) may aid in relief of acute symptoms (Thompson & Amedee,
2009).
Table 9. ICHD-3 Beta Diagnostic Criteria of Vestibular Migraine
A
B
C
D

At least five episodes filling criteria for (C) and (D)
Current or past history of migraine, either with or without aura, considering the International
Classification of Headache Disorders (ICHD) criteria
Moderate or severe vestibular symptoms lasting 5 minutes to 72 hours
At least half of the episodes are associated with at least one of these migraines associated
features:
1. Headache with at least two of the following characteristics
• Unilateral location
• Pulsating quality
• Moderate or severe intensity
• Aggravation by routine physical activity
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2. Photophobia and phonophobia
3. Visual aura
No other better diagnostic explanation

E

Vertebrobasilar Ischemic Stroke
The vertebrobasilar system supplies blood to the brainstem, cerebellum and the inner ear.
The three major branches are the posterior inferior cerebellar artery, the anterior inferior
cerebellar artery and the superior cerebellar artery. Occlusion of any one of these major branches
can result in vertigo. Depending on the location of the lesion, symptoms will vary (Thompson &
Amedee, 2009). Occlusion of the posterior inferior cerebellar artery results in lateral medullary
infarction, which leads to lateral medullary syndrome also known as Wallenberg’s syndrome.
Occlusion of the anterior inferior cerebellar artery results in lateral pontomedullary infarction.
Occlusion of the superior cerebellar artery results in lateral superior pontine syndrome. A patient
presenting with strictly vertiginous symptoms should be evaluated for a vertebrobasilar ischemic
stroke. Evaluation should include a neurology consultation, physical evaluation and imaging
(Thompson & Amedee, 2009).
Table 10. Classification of vertebrobasilar ischemic stroke
Lateral Medullary Infarction
•
•
•
•
•
•
•
•
•
•

Vertigo
Nystagmus
Gait disturbance
Ipsilateral limb ataxia
Facial pain/numbness
Contralateral body
hemianesthesia
Horner’s syndrome
Dysphagia
Hoarseness
Facial nerve paralysis
(rare)

Lateral Pontomedullary
Infarction
•

•

Similar symptoms to
Wallenberg’s syndrome
with the exception of
hoarseness and dysphagia
Involvement of cranial
nerves VII and VIII results
in ipsilateral facial
paralysis, tinnitus and
hearing loss

31

Lateral Superior Pontine
Syndrome
•
•
•
•
•
•
•
•

Vertigo
Nystagmus
Gait disturbance
Ipsilateral limb ataxia
Facial pain/numbness
Contralateral body
hemianesthesia
Horner’s syndrome
Contralateral impairment
of vibration and
temperature due to
involvement of the medial
lemniscus

Vestibulotoxic Drugs
Ototoxicity is the result of certain medications and/or chemicals that cause damage to the
inner ear that leads to functional impairment and degeneration of the inner ear. Ototoxins can
take the form of medications, heavy metals or chemical vapors. Iatrogenic ototoxicity occurs
when a drug is administered in hopes of improving a person’s health. Unfortunately, the drug
used to treat, prevent or diagnose the medical condition negatively affects other aspects of the
person’s health (Myers, 2015).
When determining the presence and cause of ototoxicity, an in-depth case history and
medication history is helpful. Case history should pertain to conditions that could put the patient
at risk for ototoxicity. This includes any general health problems, dehydration, sensitivity to
medications and any past ototoxic reactions, such as tinnitus from a previous medication.
Medication history questions should pertain to ototoxic agents. This includes any past ototoxic
drug use, long history of medication use, and verification of appropriate dosage of previous and
current medications. A list of past and current medications will be beneficial, especially those
taken preceding a change in hearing or the development of tinnitus or vertigo (Myers, 2015).
Ototoxic substances travel through the body. Once the substance has moved through the
gastrointestinal system, the drug is completely absorbed into the bloodstream. When an ototoxic
agent is present in the bloodstream, it enters the inner ear. The blood supply to the inner ear is
critical for normal hearing and vestibular function. While the kidneys serve as the body’s
eliminator of waste including ototoxic substances, the system is not fool proof and any problems
with the kidneys will enhance ototoxic effects (Myers, 2015).
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The physiological basis of ototoxicity refers to the mechanisms that cause auditory
structures to die. These two basic mechanisms are programmed cell death (PCD) and necrosis.
PCD is a naturally occurring action that involves a set of molecular events that have been
programmed into the genetic nature of the cell. In other words, a genetic code that will determine
how long a cell will live. Necrosis is the death of a structure and is usually caused from stress or
damage. Necrosis can occur by mechanical means – such as high intensity noise exposure which
causes damage in the first turn of the cochlea; lack of blood or nutrition, and/or exposure to toxic
organisms, agents, or chemicals (Myers, 2015).
Symptoms of ototoxicity vary depending if they are cochleotoxic (toxic to the cochlea) or
vestibulotoxic (toxic to the vestibular system). Bilateral sensorineural hearing loss is a
cochleotoxic effect. It can be temporary, but it is usually irreversible. The hearing loss can occur
in various patterns, but the first signs usually occur in the extended high frequencies (above 8000
Hz). Besides hearing loss, some drugs cause hearing to be distorted. The change in hearing
should correspond with the start or increased dosage of the ototoxic drug. Whether or not the loss
will be temporary or permanent is dependent on the causative agent and the dosage as ototoxicity
is related to dosing levels. For example, high doses of aspirin can be ototoxic but small,
occasional doses are not ototoxic. In addition to sensorineural hearing loss, tinnitus is also a
cochleotoxic effect. Tinnitus is a very common effect and is the number one indicator of
ototoxicity. Ototoxic substances can cause new tinnitus or exacerbate pre-existing tinnitus.
Another symptom of cochleotoxicity is aural fullness (Myers, 2015).
Vestibulotoxic effects may occur with or without cochleotoxicity. Vestibulotoxic effects
are generally characterized by dizziness, vertigo, ataxia, nystagmus and/or oscillopsia. These
balance disturbances are associated with aminoglycosides, antimalarial drugs, antineoplastic
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drugs, and loop diuretics. Vestibulotoxic symptoms can occur due to therapeutic vestibular
ototoxicity. These are ototoxic drugs introduced to reduce the effects of vestibular pathologies,
such as Gentamicin – an aminoglycoside – used for treatment of endolymphatic hydrops.
Listed below is information regarding commonly prescribed and known ototoxic agents.
Information has been adapted from Dr. Michael Meyers, AuD.
Aminoglycosides
Along with Gentamycin, other aminoglycosides are known ototoxic drugs.
Aminoglycosides are antibiotics used to rid the body of bacteria in life threatening situations.
The overall incidence of ototoxicity for patients taking aminoglycosides is 8 percent (Love,
VandeWaa, DeRuiter & Ramachandran, 2013). When aminoglycosides are administered orally
or topically they are not typically ototoxic. IV and injection aminoglycosides, however, can be
ototoxic. These substances are cochleo-vestibulotoxic (affecting both the auditory and vestibular
systems) and the effects are usually not reversible. Aminoglycosides such as Streptomycin and
Gentamicin are primarily vestibulotoxic. Neomycin, Amikacin, and Kanamycin are primarily
cochleotoxic. Tobramycin has the potential for cochlear and vestibular damage. With multiple
aminoglycoside treatments, the patient is at an increased risk during the additional rounds.
Loop Diuretics
Loop diuretics are used to remove excess fluid. When administered orally, there is a low
ototoxic risk. When administered intravenously, there is a high ototoxic risk. Ototoxic effects are
almost instantaneously and may occur within minutes after administration of high doses or rapid
IV infusion (Love, VandeWaa, DeRuiter & Ramachandran, 2013). Fortunately, these effects
typically recover within 24-72 hours of final dosing. Loop diuretics have cochlea-vestibulotoxic
effects. Usually, the hearing loss will resolve within 24-48 hours. Occasionally vestibular
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symptoms occur. Examples of ototoxic loop diuretics include Furosemide, Bumetaside,
Ethracrynic acid, and Torsemide. If aminoglycosides are given first within 8 hours of loop
diuretics, there is an increased ototoxic effect since aminoglycosides affect cell permeability.
Non-steroidal Anti-Inflammatory Drugs
Non-steroidal Anti-Inflammatory Drugs (NSAIDS) are another family of ototoxic drugs.
These are used as pain relievers, fever reducers and as salicylates. NSAIDS are administered
orally and have cochlea-vestibulotoxic effects that are typically reversible. Hearing loss from
NSAIDS is typically high frequency but may be flat. Ototoxic effects are dose related and effects
disappear 24-72 hours after discontinuing use of the medication. Examples of NSAIDS include
salicylates, ibuprofen, naproxen, indomethacin, and acetaminophen. Abuse of Vicodin
(acetaminophen and codeine) may result in irreversible, profound hearing loss.
Chemotherapeutic Agents
Chemotherapeutic agents such as Cisplatin, Carboplatin, Vinblastine and Vincristine are
known ototoxins. Platinum based anti-neoplastic agents carry the most ototoxic effects, which
are not usually reversible. These are intravenous drugs used in oncologic treatments. Ototoxic
effects are dose and age related. Those 5 years old and under and those above 46 years of age
have a higher risk of susceptibility. These agents primarily cause outer hair cell damage and
often tinnitus, which can be transient.
Anti-malarials
Anti-malarials such as quinine have effects similar to aspirin and they are usually
reversible with discontinuation. Cinchonism is a syndrome resulting from Quinine that leads to
hearing loss, dizziness, headaches, nausea, and vision changes. Organic solvents such as styrene,
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toluene, trichloroethylene, and butyl nitrate are known ototoxic chemicals. Janitors, assemblers,
printing machine operators and laundromat workers are all at risk to these chemicals. Lastly,
heavy metals such as mercury, manganese, and lead can be ototoxic.
Table 11. Classification of common ototoxic medications

MEDICATION

CLASSIFICATION

PRIMARY
OTOTOXICITY

PERMANENT OR
REVERSIBLE

Acetaminophen

NSAID

Cochleo-vestibulotoxic

Reversible

Amikacin

Antibiotic

Cochleotoxic

Permanent

Bumetaside

Diuretic

Cochleo-vestibulotoxic

Reversible

Carboplatin

Chemotherapy agent

Cochleotoxic

Permanent

Cisplatin

Chemotherapy agent

Cochleotoxic

Permanent

Ethracrynic acid

Diuretic

Cochleo-vestibulotoxic

Reversible

Furosemide

Diuretic

Cochleo-vestibulotoxic

Reversible

Gentamicin

Antibiotic

Vestibulotoxic

Permanent

Ibuprofen

NSAID

Cochleo-vestibulotoxic

Reversible

Indomethacin

NSAID

Cochleo-vestibulotoxic

Reversible

Kanamycin

Antibiotic

Cochleotoxic

Permanent

Naproxen

NSAID

Cochleo-vestibulotoxic

Reversible

Neomycin

Antibiotic

Cochleotoxic

Permanent

Quinine

Anti-malarial

Cochleo-vestibulotoxic

Reversible

Salicylates

NSAID

Cochleo-vestibulotoxic

Reversible

Streptomycin

Antibiotic

Vestibulotoxic

Permanent

Tobramycin

Antibiotic

Cochleo-vestibulotoxic

Permanent

Torsemide

Diuretic

Cochleo-vestibulotoxic

Reversible

Vancomycin

Antibiotic

Cochlea-vestibulotoxic

Permanent
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Vicodin

NSAID

Cochleo-vestibulotoxic

Permanent

Vinblastine

Chemotherapy agent

Cochleotoxic

Permanent

Vincristine

Chemotherapy agent

Cochleotoxic

Permanent

Vestibulotoxic effects are harder to monitor than cochleotoxic effects. Vestibular results
are highly variable and there is no standard baseline or monitoring protocol. Bedside testing
including head shake nystagmus, head thrust testing, dynamic visual acuity, and postural control
can be done but it is difficult. Laboratory testing such as
electronystagmography/videonystagmography (ENG/VNG), rotary chair, and dynamic
posturography can also be done in an attempt to monitor vestibular effects. In order to properly
monitor ototoxicity, a multidiscipline approach should be used. This involves various
instruments, coordination of efforts between different health professionals, patient factors, and
costs.
Several ototoxic risk factors have been identified that increase ototoxic effects. Certain
genetic anomalies can cause aminoglycoside antibiotics to recognize genes as bacteria, which
causes hearing loss. Grapefruit juice is another risk factor as it can prevent the breakdown of
certain medication, which causes medications to stay in their unbroken state and in the body for
an extended time. The liver won’t metabolize the way it should which causes increased ototoxic
effects. Polypharmacy can increase ototoxic effects. As we age, risk for ototoxicity occurs due to
a slowing metabolism, increased likelihood of polypharmacy and malnourishment. Lastly, noise
is a risk factor. Exposure to noise during or after some drug treatment or chemical exposure can
be synergistic. Ways to reduce ototoxicity risk factors include: discussing medication effects
with doctors, following dosage instructions, awareness of ototoxicity signs, informing physician
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of pre-existing cochlear, vestibular, and/or renal issues, avoiding dehydration, avoiding
polypharmacy, avoiding noisy environments, establishing audiometric/vestibular function
baseline, and if chemotherapy is necessary – administer chemotherapy drugs before radiation to
reduce ototoxic risk.
As healthcare professionals, the goal should be to prevent cell death in the auditory
system to maintain a promising quality of life for our aging patient population. This can be done
with treatments, rehabilitation, and prevention techniques. Additionally, early identification will
play a role in the prevention of cell death. With early identification, it is possible to treat a
condition with less ototoxic medications. To do this, healthcare professionals need to create
relationships with hearing healthcare professionals – such as audiologists or otolaryngologists –
to exchange information and to provide referrals in regard to any auditory or vestibular changes
from medications. Additionally, if warranted, in-service education by an audiologist can aid in
building a team approach to prevent ototoxic effects.
Unfortunately, early identification can only go so far. Depending on the condition, less
ototoxic medication is not always an option. In this situation, early intervention can help prevent
the progression of ototoxic effects. It is important to maintain communication with your patients
and an audiologist as ototoxic effects progress. Rehabilitation programs can be effective to
prepare the patient and create a proactive program for the progression.
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Appendices
The information presented in this healthcare guide is provided to increase awareness of
vestibular degeneration and dysfunction in the aging population. Below are additional handouts
and questionnaires to be implemented into your daily practice should you encounter the dizzy
patient.
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Appendix A. Vertigo handout

SPINNING OUT OF CONTROL
WHEN A SYMPTOM BECOMES UNSAFE

What is vertigo?
The feeling that oneself or the room is spinning. It is a
symptom – not a disease.

Who has vertigo?

What causes vertigo?

40% of the US population
will likely suffer from a
dizziness or balance
problem in their lifetime

Balance problems
Heart disease
Anxiety
Medication
Head trauma
Infection/Virus
Diabetes
Stroke
& many more!

69 million Americans age
40+ suffer from vertigo
related to some type of
vestibular disorder

Is vertigo dangerous?
Did you ever spin around in circles as a child and fall over?
Vertigo is like that – except without the fun and games. It
can be harmless but it can also be harmful if it causes to falls.
Falls can be minor and result in bumps and bruises or they
can be major and result in broken bones and even death.
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SPINNING OUT OF CONTROL
TIPS TO STAY SAFE & PREVENT FALLS

Talk to your doctor
An apple a day may keep the doctor away, but it won’t save you from a bad
fall. Talk to your doctor about your risk factors and what you can do to
prevent falling. They can give you information about local fall safety programs.

Manage your medications
Ask your doctor if there are any side effects that could increase your risk of
falling.

Get your eyes & ears checked
Your eyes and ears help you to see and hear any danger. They also help you
keep your balance. Make sure to take care of both and schedule yearly checkups.

Get moving!
Join a local workout program to build strength and improve balance.

Make your home safe
Make sure every room has bright lighting. Pick up clutter to reduce tripping
hazards. Install stair railings. Use non-slip mats in the bathroom. Mark steps
with caution tape. Simple changes can make a big difference.

Talk to your friends & family
Falls can cause harm that other cannot see. Fear of falling can cause stress and
harmful feelings. Don’t keep these feelings to yourself. Talking to a loved one
can help you cope with what you are going through. Support can help keep
you safe.
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Appendix B. Dizziness Handicap Inventory
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Appendix C. Initial Referral Guide Based on Primary Symptom

Hearing Loss

Sudden hearing loss

Audiology

Emergency Dept. & Audiology

Refer for Hearing
Evaluation

Refer for imaging (MRI,CT) &
baseline hearing test

Tinnitus

Vertigo

ENT & Audiology

ENT &Audiology

Refer for hearing evaluation,
tinnitus evaluation, possible
imaging

Refer for estibular
evaluation: VNG,
cVEMP, oVEMP, vHIT
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Ear drainage

Ear pain

ENT

ENT

Refer for
otologic
evaluation

Refer for
otologic
evaluation

Migraine

Neurology

Refer for neurological
evaluation & possible
imaging (MRI/CT)
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